ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

Figure 8

ADAMTSL4 predicted worse survival in IDH1/2 wild-type GBM WHO grade IV. The overall survival of high- and low-ADAMTSL4 expression in the CGGA (a) and TCGA (b) database is quite different. IDH1/2 wt: IDH1/2 wild-type.

(a) CGGA IDH1/2 wt

(b) TCGA IDH1/2 wt